Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Dishman Carbogen Amcis Ltd - 540701 - NEWSPAPER ADVERTISEMENT FOR INFORMATION REGARDING THE ANNUAL GENERAL MEETING TO BE HELD THROUGH VIDEO CONFERENCING OR OTHER AUDIO VISUAL MEANS

 Please find enclosed copies of the newspaper advertisement published on 23rd August, 2022 in 'Indian Express' in its English edition and in 'Financial Express' in its Gujarati edition daily newspapers, informing the shareholders about the Annual General Meeting to be held on Thursday, 29th September, 2022 at 03:00 p.m. IST through Video Conferencing or Other Audio Visual Means, in accordance with relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India.
23-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - INTIMATION REGARDING DATE OF 15TH ANNUAL GENERAL MEETING

 This is to inform that Annual General Meeting ('AGM') of members of the Company is scheduled to be held on Thursday, 29th September, 2022 at 03:00 p.m. IST through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') in accordance with relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. Further details on the manner of attending the AGM and casting votes by shareholders will be set out in the Notice of the 15th AGM which will be sent to the Shareholders in due course.
22-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, pls. find enclosed herewith transcript of earnings conference call arranged by the Company with Investors on Wednesday, 10th August, 2022 to discuss the financial result and performance of the Company for the quarter ended on 30th June, 2022. The aforesaid transcript is also being hosted on the website of the Company, www.imdcal.com in accordance with the Regulation 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
13-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, the audio recording of Conference Call arranged by the Company with Investors on Wednesday, 10th August, 2022 at 17:15 hrs. (IST) to discuss the financial result and performance of the Company for the quarter ended on 30th June, 2022 is available on the Company's website at https://imdcal.com/images/files/Investor-Relations/Investor%20Call/Audio-Video%20Recording/2022-23/Q1%20Result%20-%20Audio%20Recording%20-%2010.08.2022.mp3
10-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to our intimation dated 9th August, 2022 regarding conference call, this is to intimate that Conference Call with Investors was scheduled to be held on Wednesday, 10th August, 2022 at 16:00 hrs. (IST) is hereby re-scheduled and now to be held on Wednesday, 10th August, 2022 at 17:15 hrs. (IST) to discuss the financial result and performance of the Company for the quarter ended on 30th June, 2022. Please note that details of dial in numbers of Conference Call are remain same as mentioned in our intimation dated 9th August, 2022, which are mentioned in the attached file.
10-08-2022
Bigul

Q1FY23 Quarterly Result Announced for Dishman Carbogen Amcis Ltd.

 Pharmaceuticals firm Dishman Carbogen Amcis announced Q1FY23 Result : Net Revenue at Rs 5,406.1 mn in Q1 FY23 down by 1.8% YoY mainly on account of lower revenues from Netherlands business. Dishman Carbogen Amcis - NCE APIs and Intermediates revenue increased by 91.9% YoY primarily due to: Increased supplies of APIs and intermediates from Bavla site driven by successful customer audits. Dishman Carbogen Amcis - Quats and Generics revenue increased by 7.1% YoY primarily due to: Increased demand for these products especially in the exports market driven by exceptional operational performance by Naroda site. Carbogen Amcis - CRAMS revenue increased by 3.0% YoY primarily due to: Higher Development revenue comprising 70% of the total revenue for the quarter. Carbogen Amcis - Cholesterol and Vitamin D analogues revenue decreased by 46.0% YoY primarily due to: Carbogen Amcis BV’s Q1FY22 revenue was almost 38% of the total year’s revenue, thus extremely front ended, which is not the case this year. One of the customers last year had stocked up huge amount of inventory in June quarter. EBITDA Margin at 16.3% in Q1 FY23 compared to 18.3% in Q1 FY22 due to: Higher energy costs and higher raw material costs impacted the cost base significantly in Carbogen Amcis BV in the first quarter as compared to last year same quarter. Higher logistics costs has also impacted the cost base globally. One time FX loss impact approximately Rs. 9.00 crores as part of “Other Expenses” Result PDF
10-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith Presentation on financial result for the first quarter ended 30th June, 2022 to be made to Analyst and Investors. The aforesaid presentation is also being hosted on the website of the Company, www.1mdcal.com in accordance with the Regulation 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
09-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company has arranged Conference Call with Investors on Wednesday, 10th August, 2022 at 16:00 hrs. (IST) to discuss the financial result and performance of the Company for the quarter ended on 30th June, 2022. The details of dial in numbers of Conference Call are as mentioned in attached file.
09-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS' LIMITED REVIEW REPORT FOR THE QUARTER ENDED 30/06/2022

 We hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Tuesday, the 9th day of August, 2022 which was commenced at 1:30 P.M. and concluded at 06:25 P.M., inter alia, have approved the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2022, which is attached herewith along with Statutory Auditors' Limited Review Report dated 9th day of August, 2022 signed by M/s. T R Chadha & Co LLP, Chartered Accountants, in respect of the Un-audited Financial Results of the Company for the quarter ended on 30th June, 2022, prepared in terms of Regulation 33 of SEBI (LODR) Regulations, 2015.
09-08-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Intimation for Consideration Of Un-Audited Financial Result For The First Quarter Ended 30Th June, 2022.

 Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve Un-Audited Financial Result of the Company for the First Quarter ended 30th June, 2022.
02-08-2022
Next Page
Close

Let's Open Free Demat Account